论文部分内容阅读
目的:探讨分析泮托拉唑治疗幽门螺杆菌阳性消化性溃疡合并上消化道出血患者的临床疗效研究。方法:随机抽取86例幽门螺杆菌阳性消化性溃疡合并上消化道出血患者的临床资料,将其分为治疗组(泮托拉唑)与对照组(奥美拉唑)两组,进行系统性分析。结果:两组治疗对比后有显著差异(P<0.05),治疗组有效率(91.4%)明显高于对照组(76.7%)。结论:泮托拉唑治疗幽门螺杆菌阳性消化性溃疡并上消化道出血临床疗效显著,且无不良反应,可作为临床首选药物。
Objective: To investigate the clinical efficacy of pantoprazole in the treatment of Helicobacter pylori-positive peptic ulcer patients complicated with upper gastrointestinal bleeding. Methods: The clinical data of 86 patients with Helicobacter pylori-positive peptic ulcer combined with upper gastrointestinal bleeding were randomly divided into two groups: treatment group (pantoprazole) and control group (omeprazole) analysis. Results: There was significant difference between the two groups after treatment (P <0.05). The effective rate (91.4%) in the treatment group was significantly higher than that in the control group (76.7%). Conclusion: Pantoprazole is effective in the treatment of H.pylori - positive peptic ulcer with upper gastrointestinal hemorrhage. It has good clinical efficacy and no side effects. It can be used as the first choice of clinical medicine.